MedPath

A study to evaluate the dose of propofol for general anaesthesia considering the weight of the patient

Phase 4
Conditions
Health Condition 1: null- ASA I & II patients, between age group18-60yrs with BMI (30-40kg/m2), undergoing elective laparoscopic surgery under general anaesthesia for atleast 30 minutes and maximum of 3 hours
Registration Number
CTRI/2017/10/010044
Lead Sponsor
Dr L H Hiranandani Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients undergoing elective laparoscopic surgery with BMI between 30 and 40, ASA 1and 2 under general anaesthesia for a minimum duration of 30 minutes to maximum of 3 hours

Exclusion Criteria

1.History of significant cardiac pulmonary, liver or renal disease.

2. Patient scheduled for awake bronchoscopic intubation.

3. Previous history of cerebrovascular accident, other neurological disorders and those on long term drugs affecting CNS (chronic BZDâ??s/ opioids)

4. Allergy to propofol.

5. Patients with significant hemodynamic changes intraoperatively, fall of Mean arterial blood pressure by more than 20% of baseline,intraoperative entropy of more than 60 for more than 10 minutes and need to add inhalational agent will be excluded.

6) patients refusal to be included in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath